|
CCNA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36934907857267E-12 |
| Normal-vs-Stage2 |
4.615800E-04 |
| Normal-vs-Stage3 |
1.81310000002544E-06 |
| Normal-vs-Stage4 |
8.041300E-03 |
| Stage1-vs-Stage2 |
3.252200E-01 |
| Stage1-vs-Stage3 |
2.003600E-03 |
| Stage1-vs-Stage4 |
5.829800E-02 |
| Stage2-vs-Stage3 |
3.241700E-02 |
| Stage2-vs-Stage4 |
1.209390E-01 |
| Stage3-vs-Stage4 |
6.854800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.80679999850497E-08 |
| Normal-vs-Asian |
1.621690E-02 |
| Caucasian-vs-AfricanAmerican |
9.625800E-01 |
| Caucasian-vs-Asian |
1.124170E-01 |
| AfricanAmerican-vs-Asian |
9.929900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.7412994924324E-10 |
| Male-vs-Female |
1.400610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.80990000004022E-06 |
| Normal-vs-Extreme_Weight |
2.71105360383217E-12 |
| Normal-vs-Obese |
6.97830004892097E-09 |
| Normal-vs-Extreme_Obese |
9.015900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.257220E-01 |
| Normal_Weight-vs-Obese |
8.655400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.172000E-01 |
| Extreme_Weight-vs-Obese |
3.844400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.573800E-01 |
| Obese-vs-Extreme_Obese |
7.287600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.616590E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(61-80Yrs) |
5.97977223293356E-12 |
| Normal-vs-Age(81-100Yrs) |
6.322300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.599900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.182000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.192330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.446980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.179000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.262200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.3329999982179E-08 |
| Normal-VS-KIRP CIMP |
8.427300E-04 |
| Normal-VS-Unclassified PRCC |
2.94670000000608E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.076570E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.076300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.576390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.678900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.904400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.940500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31920000479013E-08 |
| Normal-vs-N1 |
6.39370000055095E-07 |
| Normal-vs-N2 |
9.070100E-02 |
| N0-vs-N1 |
4.809000E-04 |
| N0-vs-N2 |
8.379500E-02 |
| N1-vs-N2 |
4.833000E-01 |
|
|
